Bristol Myers Squibb ends blood cancer drug deal with Cellares

Pharmaceutical giant Bristol Myers Squibb has terminated its partnership agreement with cell therapy company Cellares regarding the development of a blood cancer treatment.

25 Aug, 16:58 — 25 Aug, 16:58

Post Share

Sources

Showing 1 of 1 sources

ReutersVery High6d ago

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters

Read full article →

Bristol Myers Squibb ends blood cancer drug deal with Cellares

Sources

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters

Related Stories

Lionel Richie Hospitalized in Intensive Care After Concert Illness

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue